Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fruquintinib”

169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 169 results

Large-scale testing (Phase 3)Study completedNCT02314819
What this trial is testing

A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO)

Who this might be right for
Colorectal Cancer
Hutchison Medipharma Limited 416
Testing effectiveness (Phase 2)UnknownNCT05451719
What this trial is testing

Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy

Who this might be right for
Colorectal CancerColorectal Cancer Stage IV
Fudan University 116
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07510932
What this trial is testing

Fruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients (FIRST-K)

Who this might be right for
Colon Cancer
Korea University Anam Hospital 88
Early research (Phase 1)Study completedNCT03251378
What this trial is testing

A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers

Who this might be right for
Advanced Solid TumorsMetastatic Colon CancerMetastatic Breast Cancer+4 more
Hutchison Medipharma Limited 129
Testing effectiveness (Phase 2)Study completedNCT04716634
What this trial is testing

Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors

Who this might be right for
Advanced Solid Tumors
BeiGene 84
Not applicableNot Yet RecruitingNCT05928312
What this trial is testing

Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Zhejiang Cancer Hospital 72
Testing effectiveness (Phase 2)Looking for participantsNCT07136077
What this trial is testing

Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Who this might be right for
Minimal Residual DiseaseAdjuvant ChemotherapyColorectal Cancer+3 more
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07170982
What this trial is testing

Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer

Who this might be right for
Endometrial Cancer
Sun Yat-sen University 128
Testing effectiveness (Phase 2)Looking for participantsNCT07011576
What this trial is testing

Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colon CancerRectal CancerColorectal Cancer+1 more
SCRI Development Innovations, LLC 60
Testing effectiveness (Phase 2)UnknownNCT05447715
What this trial is testing

Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Weijian Guo 134
Early research (Phase 1)Study completedNCT05216354
What this trial is testing

Fruquintinib Renal Impairment Study

Who this might be right for
Renal Impairment
Hutchmed 24
Not applicableLooking for participantsNCT07035886
What this trial is testing

Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea

Who this might be right for
Colorectal Cancer
Takeda 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT05177068
What this trial is testing

Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer
Henan Cancer Hospital 42
Not applicableLooking for participantsNCT06787105
What this trial is testing

Fruquintinib in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
iOMEDICO AG 150
Testing effectiveness (Phase 2)Study completedNCT02415023
What this trial is testing

A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Hutchison Medipharma Limited 34
Early research (Phase 1)Study completedNCT01955304
What this trial is testing

Food Effect Study of Single Dose of Fruquintinib (HMPL-013) in Healthy Subjects

Who this might be right for
Food Effect of Fruquintinib in Health Subjects
Hutchison Medipharma Limited 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT05914610
What this trial is testing

Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Fujian Medical University 100
Not applicableLooking for participantsNCT06102759
What this trial is testing

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Study completedNCT04645940
What this trial is testing

Fruquintinib Food Effect and Proton Pump Inhibitor Study

Who this might be right for
Drug InteractionFood-drug Interaction
Hutchison Medipharma Limited 14
Testing effectiveness (Phase 2)Looking for participantsNCT06406426
What this trial is testing

Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Cadonilimab and Fruquintinib Combined With Paclitaxel-albumin

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Fudan University 40
Load More Results